210 related articles for article (PubMed ID: 7941194)
21. Difficulties of a surveillance study omitting retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germ cell tumors of the testis.
Pizzocaro G; Zanoni F; Salvioni R; Milani A; Piva L; Pilotti S
J Urol; 1987 Dec; 138(6):1393-6. PubMed ID: 2824862
[TBL] [Abstract][Full Text] [Related]
22. Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors: indications and limitations.
Rassweiler JJ; Seemann O; Henkel TO; Stock C; Frede T; Alken P
J Urol; 1996 Sep; 156(3):1108-13. PubMed ID: 8709319
[TBL] [Abstract][Full Text] [Related]
23. Evolution and controversies in the management of low-stage nonseminomatous germ-cell tumors of the testis.
Pizzocaro G; Nicolai N; Salvioni R
World J Urol; 1994; 12(3):113-9. PubMed ID: 7524920
[TBL] [Abstract][Full Text] [Related]
24. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous testicular tumor.
Janetschek G; Reissigl A; Peschel R; Hobisch A; Bartsch G
Urology; 1994 Sep; 44(3):382-91. PubMed ID: 8073551
[TBL] [Abstract][Full Text] [Related]
25. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis.
Heidenreich A; Sesterhenn IA; Mostofi FK; Moul JW
Cancer; 1998 Sep; 83(5):1002-11. PubMed ID: 9731905
[TBL] [Abstract][Full Text] [Related]
26. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors.
Aprikian AG; Herr HW; Bajorin DF; Bosl GJ
Cancer; 1994 Aug; 74(4):1329-34. PubMed ID: 8055456
[TBL] [Abstract][Full Text] [Related]
27. A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only.
Nicolai N; Miceli R; Artusi R; Piva L; Pizzocaro G; Salvioni R
J Urol; 2004 Jan; 171(1):172-6. PubMed ID: 14665870
[TBL] [Abstract][Full Text] [Related]
28. Retroperitoneal lymph node dissection for the management of clinical stage I nonseminoma.
Foster RS; Donohue JP
J Urol; 2000 Jun; 163(6):1788-92. PubMed ID: 10799183
[TBL] [Abstract][Full Text] [Related]
29. The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours.
Spermon JR; De Geus-Oei LF; Kiemeney LA; Witjes JA; Oyen WJ
BJU Int; 2002 Apr; 89(6):549-56. PubMed ID: 11942962
[TBL] [Abstract][Full Text] [Related]
30. Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in low stage nonseminomatous testis cancer.
Foster RS; Baniel J; Leibovitch I; Curran M; Bihrle R; Rowland R; Donohue JP
J Urol; 1996 Jun; 155(6):1943-5. PubMed ID: 8618293
[TBL] [Abstract][Full Text] [Related]
31. Localization of solitary and multiple metastases in stage II nonseminomatous testis tumor as basis for a modified staging lymph node dissection in stage I.
Weissbach L; Boedefeld EA
J Urol; 1987 Jul; 138(1):77-82. PubMed ID: 3599225
[TBL] [Abstract][Full Text] [Related]
32. Unilateral laparoscopic retroperitoneal lymphadenectomy for clinical stage I nonseminomatous testicular cancer.
Giusti G; Beltrami P; Tallarigo C; Bianchi G; Mobilio G
J Endourol; 1998 Dec; 12(6):561-6. PubMed ID: 9895263
[TBL] [Abstract][Full Text] [Related]
33. Retroperitoneal laparoscopic lymph node dissection for staging non-seminomatous germ cell tumors before and after chemotherapy.
Rassweiler JJ; Henkel TO; Stock C; Seemann O; Frede T; Alken P
Lymphology; 1996 Mar; 29(1):36-44. PubMed ID: 8721978
[TBL] [Abstract][Full Text] [Related]
34. Predictive parameters in biologic assessment of low-stage retroperitoneal lymph-node dissection.
Albers P; deRiese W; Walker EB; Ulbright TM; Crabtree WN; Reister T; Foster RS; Donohue JP
World J Urol; 1994; 12(3):120-4. PubMed ID: 7951336
[TBL] [Abstract][Full Text] [Related]
35. Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome.
Stephenson AJ; Bosl GJ; Motzer RJ; Kattan MW; Stasi J; Bajorin DF; Sheinfeld J
J Clin Oncol; 2005 Apr; 23(12):2781-8. PubMed ID: 15837993
[TBL] [Abstract][Full Text] [Related]
36. Reliability of diagnostic imaging after orchiectomy alone in follow-up of clinical stage I testicular carcinoma: excessive cost with potential risk.
Tesoro-Tess JD; Pizzocaro G; Zanoni F; Balzarini L; Ceglia E; Petrillo R; Musumeci R
Lymphology; 1987 Sep; 20(3):161-5. PubMed ID: 3682940
[TBL] [Abstract][Full Text] [Related]
37. Late recurrence with malignant degeneration of testicular teratoma. Case report.
Bulbul MA; Farhat W; Shabb NS; Salem Z
J Med Liban; 1998; 46(2):103-5. PubMed ID: 10095838
[TBL] [Abstract][Full Text] [Related]
38. Concordance and prediction ability of original and reviewed vascular invasion and other prognostic parameters of clinical stage I nonseminomatous germ cell testicular tumors after retroperitoneal lymph node dissection.
Nicolai N; Colecchia M; Biasoni D; Catanzaro M; Stagni S; Torelli T; Necchi A; Piva L; Milani A; Salvioni R
J Urol; 2011 Oct; 186(4):1298-302. PubMed ID: 21849196
[TBL] [Abstract][Full Text] [Related]
39. Long-term results after inferior vena caval resection during retroperitoneal lymphadenectomy for metastatic germ cell cancer.
Beck SD; Lalka SG
J Vasc Surg; 1998 Nov; 28(5):808-14. PubMed ID: 9808847
[TBL] [Abstract][Full Text] [Related]
40. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer: a long-term update.
Bhayani SB; Ong A; Oh WK; Kantoff PW; Kavoussi LR
Urology; 2003 Aug; 62(2):324-7. PubMed ID: 12893344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]